Thermosome is a startup based in Germany, 6 tracked investors.
Based in Germany, Thermosome is a startup. Brouky records 6 investors associated with the company.
Thermosome is a biotech company developing thermosensitive liposomal drug formulations to achieve targeted tumor delivery and immune stimulation; its lead candidate THE001 (DPPG2-TSL-DOX) is a thermosensitive liposomal formulation of doxorubicin being developed for locally advanced soft tissue sarcoma in combination with regional hyperthermia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.